Idiopathic Pulmonary Fibrosis:Addressing the current and future therapeutic advances along with the role of Sotatercept in the management of pulmonary hypertension
Authors:
Dalia Dhia Hadi1, Mohammed Dheyaa Marsool Marsool1*, Ali Dheyaa Marsool Marsool1, Neel Vora2, Sajjad Ghanim Al-Badri3, Nabeel Hamzah Kadhim Al-Fatlawi3, Ameer Fadhil Abbas Al Wssawi4, Abdullah Muataz Taha Al-Ibraheem1, Khadija Ali Hamza1, , Priyadarshi Prajjwal5, Mohammed Abdul Mateen6 Omniat Amir7
1Internal Medicine, University of Baghdad/Al-Kindy College of Medicine, Baghdad, Iraq
2Internal Medicine, B. J. Medical College, Ahmedabad, India
3Internal Medicine, University of Baghdad, College of Medicine, Baghdad, Iraq
4Internal Medicine, University of Al-Qadisiyah College of Medicine, Diwaniya, Iraq
5Internal Medicine, Internal Medicine, Bharati Vidyapeeth University Medical College, Pune, India
6Inernal Medicine, Internal Medicine, Shadan Institute of Medical Sciences teaching hospital and research center, Hyderabad, India
7Internal Medicine, Al Manhal Academy, Khartoum, Sudan
*Correspondence: Omniat Amir. Al Manhal Academy, Khartoum, Sudan
omniatamir123@gmail.com